93 related articles for article (PubMed ID: 10612755)
1. Functional interleukin 4 receptor and interleukin 2 receptor common gamma-chain on human non-small cell lung cancers: novel targets for immune therapy.
Essner R; Huynh Y; Nguyen T; Morton DL; Hoon DS
J Thorac Cardiovasc Surg; 2000 Jan; 119(1):10-20. PubMed ID: 10612755
[TBL] [Abstract][Full Text] [Related]
2. Functional interleukin-4 receptor and interleukin-2 receptor common gamma chain in human gastric carcinoma: a possible mechanism for cytokine-based therapy.
Essner R; Huynh Y; Nguyen T; Rose M; Kojima M; Hoon DS
J Gastrointest Surg; 2001; 5(1):81-90. PubMed ID: 11309652
[TBL] [Abstract][Full Text] [Related]
3. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
Doucet C; Giron-Michel J; Canonica GW; Azzarone B
Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
[TBL] [Abstract][Full Text] [Related]
4. Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway.
Murata T; Husain SR; Mohri H; Puri RK
Int Immunol; 1998 Aug; 10(8):1103-10. PubMed ID: 9723696
[TBL] [Abstract][Full Text] [Related]
5. Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: comparison between IL-4- and IL-13-induced signal transduction.
Murata T; Obiri NI; Puri RK
Int J Cancer; 1997 Jan; 70(2):230-40. PubMed ID: 9009165
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha.
Malabarba MG; Rui H; Deutsch HH; Chung J; Kalthoff FS; Farrar WL; Kirken RA
Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):865-72. PubMed ID: 8920992
[TBL] [Abstract][Full Text] [Related]
7. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
Oelmann E; Sreter L; Schuller I; Serve H; Koenigsmann M; Wiedenmann B; Oberberg D; Reufi B; Thiel E; Berdel WE
Cancer Res; 1995 May; 55(10):2212-9. PubMed ID: 7538048
[TBL] [Abstract][Full Text] [Related]
8. Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines.
Ling YH; Li T; Yuan Z; Haigentz M; Weber TK; Perez-Soler R
Mol Pharmacol; 2007 Aug; 72(2):248-58. PubMed ID: 17456787
[TBL] [Abstract][Full Text] [Related]
9. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4.
Kondo M; Takeshita T; Ishii N; Nakamura M; Watanabe S; Arai K; Sugamura K
Science; 1993 Dec; 262(5141):1874-7. PubMed ID: 8266076
[TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant monokines, lymphokines, and other agents on clonal proliferation of human lung cancer cell lines.
Munker M; Munker R; Saxton RE; Koeffler HP
Cancer Res; 1987 Aug; 47(15):4081-5. PubMed ID: 3038306
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.
Kawakami M; Kawakami K; Stepensky VA; Maki RA; Robin H; Muller W; Husain SR; Puri RK
Clin Cancer Res; 2002 Nov; 8(11):3503-11. PubMed ID: 12429641
[TBL] [Abstract][Full Text] [Related]
12. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870
[TBL] [Abstract][Full Text] [Related]
13. Human non-small cell lung cancer cells express a type 2 cytokine pattern.
Huang M; Wang J; Lee P; Sharma S; Mao JT; Meissner H; Uyemura K; Modlin R; Wollman J; Dubinett SM
Cancer Res; 1995 Sep; 55(17):3847-53. PubMed ID: 7641203
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition signalled through the interleukin-4/interleukin-13 receptor complex is associated with tyrosine phosphorylation of insulin receptor substrate-1.
Schnyder B; Lahm H; Woerly G; Odartchenko N; Ryffel B; Car BD
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):767-74. PubMed ID: 8645156
[TBL] [Abstract][Full Text] [Related]
15. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
Song L; Turkson J; Karras JG; Jove R; Haura EB
Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.
Luppi F; Longo AM; de Boer WI; Rabe KF; Hiemstra PS
Lung Cancer; 2007 Apr; 56(1):25-33. PubMed ID: 17175059
[TBL] [Abstract][Full Text] [Related]
17. Suramin inhibits the growth of non-small-cell lung cancer cells that express the epidermal growth factor receptor.
Fujiuchi S; Ohsaki Y; Kikuchi K
Oncology; 1997; 54(2):134-40. PubMed ID: 9075785
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction pathways for interleukin 4 and insulin in human hepatoma cells.
Chuang LM; Tai TY; Kahn RC; Wu HP; Lee SC; Lin BJ
J Biochem; 1996 Jul; 120(1):111-6. PubMed ID: 8864852
[TBL] [Abstract][Full Text] [Related]
19. Activation of STAT6 is not dependent on phosphotyrosine-mediated docking to the interleukin-4 receptor and can be blocked by dominant-negative mutants of both receptor subunits.
Moriggl R; Erhardt I; Kammer W; Berchtold S; Schnarr B; Lischke A; Groner B; Friedrich K
Eur J Biochem; 1998 Jan; 251(1-2):25-35. PubMed ID: 9492265
[TBL] [Abstract][Full Text] [Related]
20. The chimeric receptor between interleukin-2 receptor beta chain and interleukin-4 receptor transduces interleukin-2 signal.
Izuhara K; Miyajima A; Harada N
Biochem Biophys Res Commun; 1993 Feb; 190(3):992-1000. PubMed ID: 7679903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
